Form 8-K

8-K — Drugs Made In America Acquisition Corp.

Accession: 0001213900-26-041284

Filed: 2026-04-08

Period: 2026-04-07

CIK: 0002028614

SIC: 6770 (BLANK CHECKS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — ea0285527-8k_drugs.htm (Primary)

EX-10.1 — LETTER OF INTENT (ea028552701ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0285527-8k_drugs.htm · Sequence: 1

false

0002028614

2026-04-07

0002028614

dei:FormerAddressMember

2026-04-07

0002028614

DMAA:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOneeighthOfOneOrdinaryShareMember

2026-04-07

0002028614

DMAA:OrdinarySharesParValue0.0001PerShareMember

2026-04-07

0002028614

DMAA:RightsEachEntitlingHolderToReceiveOneeighthOfOneOrdinaryShareMember

2026-04-07

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the

Securities Exchange Act of 1934

April 7, 2026

Date of Report (Date of earliest event reported)

Drugs Made In America Acquisition Corp.

(Exact Name of Registrant as Specified in Charter)

Cayman Islands

001-42467

99-2394788

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(I.R.S. Employer

Identification Number)

420 Lexington Avenue, Suite 1402

New York, NY

10170

(Address of Principal Executive Offices)

(Zip Code)

646-726-7074

Registrant’s telephone number, including

area code:

1 East Broward Boulevard; Suite 700

Fort Lauderdale, FL 33301

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

DMAAU

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

DMAA

The Nasdaq Stock Market LLC

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

DMAAR

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities

Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events

On April 7, 2026, Drugs Made in America Acquisition

Corp. (the “Company”) entered into a letter of intent (the “LOI”) with Power Analytics Global Corp., a Delaware

corporation (the “Target”) for a de-SPAC transaction resulting in Target becoming a public company. The terms of the transaction

are subject to further negotiation and execution of a business combination agreement although it is anticipated that the valuation for

Target will be approximately $1.0 billion, subject to adjustment based on due diligence, capital structure, net debt, working capital

and market conditions. A copy of the Letter of Intent is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

Exhibit

Number

Description

10.1

Letter of Intent

104

Cover Page Interactive Data File

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Dated: April 8, 2026

DRUGS MADE IN AMERICA ACQUISITION CORP.

By:

/s/ Roger Bendelac

Name:

Roger Bendelac

Title:

Chief Executive Officer

EX-10.1 — LETTER OF INTENT

EX-10.1

Filename: ea028552701ex10-1.htm · Sequence: 2

Exhibit 10.1

LETTER OF INTENT

Proposed Business

Combination

Power Analytics Global Corp (“PAGC”)

and

Drugs Made in America Acquisition Corp (“DMAA”)

Dated:

April 7, 2026

SECTION 1 – PARTIES

Power Analytics Global Corp (“PAGC”), a Delaware

corporation.

Drugs Made in America Acquisition Corp (“DMAA”),

a Cayman Islands exempted company and publicly traded special purpose acquisition company listed on Nasdaq.

SECTION 2 – PROPOSED TRANSACTION STRUCTURE

The Parties intend to enter into a definitive business combination

agreement (the “Business Combination Agreement”) pursuant to which PAGC shall combine with DMAA in a transaction intended

to qualify as a de-SPAC transaction, resulting in PAGC becoming a publicly listed company.

The structure, including merger mechanics, equity consideration,

and governance, shall be set forth in the Business Combination Agreement and related SEC filings, including a registration statement on

Form S-4.

SECTION 3 – VALUATION AND CONSIDERATION

The

transaction is expected to reflect an implied equity valuation of approximately $1,000,000,000 for PAGC, subject to customary

adjustments based on due diligence, capital structure, net debt, working capital, and market conditions.

Final consideration, including share exchange ratios and

potential earn-out provisions, shall be determined in the Business Combination Agreement.

SECTION 4 – TRUST ACCOUNT; NON-RECOURSE (S-4

ALIGNED)

DMAA maintains a trust account for the benefit of its public

shareholders (the “Trust Account”).

In accordance with

customary SPAC practice and to be reflected in the Business Combination Agreement and Form S-4, no party hereto shall have any

right, title, interest, or claim of any kind in or to the Trust Account, except as expressly provided under applicable securities

laws and the governing trust agreement.

The Trust Account shall not be used to satisfy any liabilities,

obligations, or claims arising out of this Letter of Intent or the transactions contemplated hereby.

SECTION 5 – WAIVER OF CLAIMS AGAINST TRUST (MARKET

STANDARD)

PAGC agrees that it shall not seek recourse against the

Trust Account or any funds held therein for any reason, including any claim arising out of this Letter of Intent, the Business Combination

Agreement, or the transactions contemplated thereby.

This provision is intended to be consistent with standard

SPAC transaction documentation and shall be incorporated into definitive agreements.

SECTION 6 – EXTENSION AND SPONSOR SUPPORT

The Parties acknowledge that DMAA may require stockholder

approval to extend its business combination deadline.

PAGC and/or its affiliates may support such extension through

contributions or arrangements to be defined in definitive documentation.

SECTION 7 – MINIMUM CASH CONDITION

The Business Combination Agreement is expected to include

a minimum cash condition, anticipated to be in the range of $25,000,000 to $50,000,000, subject to redemptions and final negotiation.

SECTION 8 – FINANCING AND PIPE

The Parties may pursue additional financing, including PIPE

investments or other capital raising transactions, the terms of which shall be set forth in definitive agreements.

Such financing shall be independent of the Trust Account

unless otherwise expressly agreed.

SECTION 9 – SEC PROCESS AND DISCLOSURE

The Parties intend to prepare and file with the SEC a registration

statement on Form S-4 (or equivalent), including a proxy statement/prospectus, reflecting the terms of the Business Combination Agreement.

All financial statements, pro forma information, and disclosures

shall be prepared in accordance with applicable SEC rules and PCAOB standards.

SECTION 10 – THIRD PARTY BENEFICIARY

The trustee of the Trust Account and its beneficiaries shall

be entitled to rely on and enforce Sections 4 and 5.

SECTION 11 – CONFIDENTIALITY

The existence and terms of this Letter of Intent and all

discussions shall remain confidential, except as required by law or SEC disclosure obligations.

SECTION 12 – NON-BINDING; TRANSITION TO DEFINITIVE

AGREEMENTS

This Letter of Intent is non-binding except for Sections

4, 5, 10, and 11.

The Parties agree to negotiate in good faith to enter into

a definitive Business Combination Agreement, which shall supersede this Letter of Intent in its entirety.

SIGNATURES

POWER ANALYTICS GLOBAL CORP

By:

/s/ Keith Barksdale

Name:

Keith Barksdale

Title:

Chairman

DRUGS MADE IN AMERICA ACQUISITION CORP

By:

/s/ Roger Bendelac

Name:

Roger Bendelac

Title:

CEO

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Apr. 07, 2026

Entity Addresses [Line Items]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 07, 2026

Entity File Number

001-42467

Entity Registrant Name

Drugs Made In America Acquisition Corp.

Entity Central Index Key

0002028614

Entity Tax Identification Number

99-2394788

Entity Incorporation, State or Country Code

Entity Address, Address Line One

420 Lexington Avenue

Entity Address, Address Line Two

Suite 1402

Entity Address, City or Town

New York

Entity Address, State or Province

Entity Address, Postal Zip Code

10170

City Area Code

646

Local Phone Number

726-7074

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

Entity Addresses [Line Items]

Title of 12(b) Security

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

Trading Symbol

DMAAU

Security Exchange Name

NASDAQ

Ordinary shares, par value $0.0001 per share

Entity Addresses [Line Items]

Title of 12(b) Security

Ordinary shares, par value $0.0001 per share

Trading Symbol

DMAA

Security Exchange Name

NASDAQ

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

Entity Addresses [Line Items]

Title of 12(b) Security

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

Trading Symbol

DMAAR

Security Exchange Name

NASDAQ

Former Address [Member]

Entity Addresses [Line Items]

Entity Address, Address Line One

1 East Broward Boulevard

Entity Address, Address Line Two

Suite 700

Entity Address, City or Town

Fort Lauderdale

Entity Address, State or Province

Entity Address, Postal Zip Code

33301

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressesLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOneeighthOfOneOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_OrdinarySharesParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_RightsEachEntitlingHolderToReceiveOneeighthOfOneOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: